SEC Lawsuit Alleges Biotech Firm, CEO Misled Investors About COVID-19 Tests

The U.S. Securities and Exchange Commission sued Decision Diagnostics Corp. and its chief executive for allegedly misleading investors by promising the biotechnology company could test for COVID-19 with a finger-prick of blood and provide accurate results in less than one …

from News – Insurance Journal https://ift.tt/38hQhOQ